Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

174 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Colon cancer stem cells: promise of targeted therapy.
Todaro M, Francipane MG, Medema JP, Stassi G. Todaro M, et al. Gastroenterology. 2010 Jun;138(6):2151-62. doi: 10.1053/j.gastro.2009.12.063. Gastroenterology. 2010. PMID: 20420952 Review.
It is not clear if CD133 is a marker of colon CSCs-other cell surface markers, such as epithelial-specific antigen, CD44, CD166, Musashi-1, CD29, CD24, leucine-rich repeat-containing G-protein-coupled receptor 5, and aldehyde dehydrogenase 1, have been proposed. ...
It is not clear if CD133 is a marker of colon CSCs-other cell surface markers, such as epithelial-specific antigen, CD44, CD166, Musashi-1, …
Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells.
Alessandro R, Flugy AM, Russo D, Stassi G, De Leo A, Corrado C, Alaimo G, De Leo G. Alessandro R, et al. J Cell Physiol. 2005 Apr;203(1):261-72. doi: 10.1002/jcp.20236. J Cell Physiol. 2005. PMID: 15484219
NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
Todaro M, Zerilli M, Triolo G, Iovino F, Patti M, Accardo-Palumbo A, di Gaudio F, Turco MC, Petrella A, de Maria R, Stassi G. Todaro M, et al. Arthritis Rheum. 2005 Jul;52(7):2179-91. doi: 10.1002/art.21145. Arthritis Rheum. 2005. PMID: 15986355
PED mediates AKT-dependent chemoresistance in human breast cancer cells.
Stassi G, Garofalo M, Zerilli M, Ricci-Vitiani L, Zanca C, Todaro M, Aragona F, Limite G, Petrella G, Condorelli G. Stassi G, et al. Cancer Res. 2005 Aug 1;65(15):6668-75. doi: 10.1158/0008-5472.CAN-04-4009. Cancer Res. 2005. PMID: 16061647
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.
Eramo A, Pallini R, Lotti F, Sette G, Patti M, Bartucci M, Ricci-Vitiani L, Signore M, Stassi G, Larocca LM, Crinò L, Peschle C, De Maria R. Eramo A, et al. Cancer Res. 2005 Dec 15;65(24):11469-77. doi: 10.1158/0008-5472.CAN-05-1724. Cancer Res. 2005. PMID: 16357155
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells.
Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesù G, De Maria R, Stassi G. Todaro M, et al. Cancer Res. 2006 Feb 1;66(3):1491-9. doi: 10.1158/0008-5472.CAN-05-2514. Cancer Res. 2006. PMID: 16452205
Annexin-1 downregulation in thyroid cancer correlates to the degree of tumor differentiation.
Petrella A, Festa M, Ercolino SF, Zerilli M, Stassi G, Solito E, Parente L. Petrella A, et al. Cancer Biol Ther. 2006 Jun;5(6):643-7. doi: 10.4161/cbt.5.6.2700. Epub 2006 Jun 11. Cancer Biol Ther. 2006. PMID: 16627980
MUC1 oncoprotein promotes refractoriness to chemotherapy in thyroid cancer cells.
Siragusa M, Zerilli M, Iovino F, Francipane MG, Lombardo Y, Ricci-Vitiani L, Di Gesù G, Todaro M, De Maria R, Stassi G. Siragusa M, et al. Cancer Res. 2007 Jun 1;67(11):5522-30. doi: 10.1158/0008-5472.CAN-06-4197. Cancer Res. 2007. PMID: 17545635
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4.
Todaro M, Lombardo Y, Francipane MG, Alea MP, Cammareri P, Iovino F, Di Stefano AB, Di Bernardo C, Agrusa A, Condorelli G, Walczak H, Stassi G. Todaro M, et al. Cell Death Differ. 2008 Apr;15(4):762-72. doi: 10.1038/sj.cdd.4402305. Epub 2008 Jan 18. Cell Death Differ. 2008. PMID: 18202702
174 results
Jump to page